|
| | 
|
 | |
        
|  |
 
|
 Sepracor Inc. - [Ticker: SEPR] |     | | Last Trade | 0.00 | Last Trade Time | - 00:00:00 | | Variation | N/A (N/A) | Open | 0.00 | | High | 0.00 | Low | 0.00 | | Volume | 0 | Average Volume (3m) | 0 | | Yield | | Bid / Ask | N/A | | Former Close | 0.00 | 52 Week Range | [0.00 - 0.00] | | PER | 0.00% | EPS | 0.00 | | Ex-Dividend Date | | Dividend Payment | | | Market Capitalization | 0 | 1 Year Price-Target | 0.00 | | Note: The data may have some minutes of delay. |
| | Watch more quotes |
| Last 10 Forum Topics about Sepracor Inc.: | | No topics about Sepracor Inc. [SEPR] have been found, but a search on the Forum for more topics related to Sepracor Inc. is advised. |
|
News about Sepracor Inc. [SEPR]: (ordered by relevance)
| | Lupin Signs Agreement to Acquire Two Inhalation Brands from ... Lupin
Sunovion, Sumitomo Dainippon Pharma and Otsuka Enter ... Business Wire
GoFundMe account created to benefit son of Shrewsbury woman ... MetroWest Daily News
Prilenia Expands Leadership Team, Appoints Anne Sullivan as ... Business Wire
Karuna Therapeutics Appoints William P. Kane as Chief Commercial ... Business Wire
Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics Business Wire
Shuttle Pharmaceuticals Enters into Manufacturing Agreement for ... PR Newswire
Shuttle Pharmaceuticals Provides Third Quarter 2022 Corporate ... PR Newswire
Sunovion Pharmaceuticals Inc To Acquire Elevation ... Pharmaceutical Online
Dainippon to buy U.S. drug firm Sepracor for $2.6 billion Reuters
Canada?s new patent claim fee rules: Alternative embodiments ... JD Supra
Lewy body dementia ? Do you even know what that is? MedCity News
Meta-analysis Finds Antidepressants Ineffective for Children and ... Mad in America
The Top 25 Healthcare Technology Leaders of Virginia for 2023 The Healthcare Technology Report.
Dr Chris Senanayake of TCG GreenChem Inc Wins Two Business Worldwide Magazine CEO Awards Yahoo Finance
C4 Therapeutics Appoints Experienced Clinical Development ... GlobeNewswire
The Top 25 Healthcare Technology Leaders of Washington, DC for ... The Healthcare Technology Report.
Demi Lovato Joins Forces with Sunovion and Leading Mental ... Business Wire
Demi Lovato, Sunovion and Leading Advocacy Organizations ... Business Wire
Sunovion's LatudaŽ (lurasidone HCl) Receives FDA Approval to ... Business Wire
Advice About Sleep Deficiency in Midlife, Part 1 The New York Times
The American College of Chest Physicians and Sunovion Announce ... Business Wire
Marlborough Drugmaker to Lay Off 360 Employees NBC10 Boston
Altimmune names new CEO - Washington Business Journal The Business Journals
TCG Lifesciences Pvt. Ltd. expands its footprint to the United States ... PR Newswire
FDA approves Sunovion?s Latuda to treat some cases of bipolar disorder Boston.com
Supply chains for defossilised organic chemicals European Pharmaceutical Review
3 Clinical Trials Lessons The Pandemic Taught Us Clinical Leader
Perseus Holdings USA Strengthens Board of Directors with ... PR Newswire
Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief ... PR Newswire
UPDATE 1-GeoPharma settles patent suit for generic Clarinex Reuters
Sunovion reps deployed for Latuda - MM+M - Medical Marketing ... MM+M Online
Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and ... GlobeNewswire
FDA approves Marlborough company?s epilepsy drug The Boston Globe
The Top 25 Healthcare Technology Leaders of Pennsylvania for 2023 The Healthcare Technology Report.
Ciclesonide Market Size Is Estimated to reach US$ 657.6 Million By ... Medgadget
TScan Therapeutics Formed to Overcome Challenges of Current ... Business Wire
Nautic Partners Announces Acquisition of Mikart, Inc.; Michael ... Business Wire
Sepracor's 'boxing bed' ad hit with DDMAC untitled letter MM+M Online
FDA approves new sleeping drug from Merck Daily Mail
The Top 25 Biotech CEOs of 2021 The Healthcare Technology Report.
Findings from a pilot open-label trial of N-acetylcysteine for the ... BMC Psychiatry
Insomnia The Lancet
Belgium's Ablynx enters the US market PMLiVE
Vaxxinity Appoints Dr. Peter Powchik to Board of Directors BioSpace
FDA: Here Are The New Warnings About Sleeping Pills Like Ambien, Lunesta, Sonata Forbes
Key Drug Facts Often Left off FDA Labels CBS News
CELOX LABORATORIES, INC. ANNOUNCES FORMATION OF ... Pharmaceutical Online
ADDING MULTIMEDIA Dicerna Bolsters Leadership Team to ... Business Wire
Xopenex: Dosage, side effects, uses, and more Medical News Today
ArTara Therapeutics Announces Addition of Randall Marshall, MD ... Business Wire
BioAge Raises $90M to Treat Aging and Age-related Diseases Yahoo Finance
Sandoz In-Licenses Brand And Authorized Generic Of Respiratory ... Pharmaceutical Online
FDA lowers Lunesta dose due to next-day drowsiness WUSA9.com
Adult ADHD With Anxiety and Depression: What Drives What? Medscape
Obstructive Lung Disease Market Diagnosis and Treatment ... Medgadget
Fulcrum Therapeutics Appoints Judith A. Dunn, Ph.D. as President ... GlobeNewswire
Biotech Past, Biotech Present: Reflections on the IPO Window of 1991-1994 Forbes
Allergy Treatment Market Research Report Up to 2031 openPR
An ominous trend resurfaces as new drug approvals plunge in 2013 FierceBiotech
Sitemap HME News
Ironwood Pharmaceuticals Announces Board of Directors for ... Business Wire
Levomilnacipran: A Brief Overview Medscape
POZEN And Tribute Announce Plan To Proceed With Merger To ... PR Newswire
Circadian misalignment affects sleep and medication use before ... Nature.com
10 Hilarious Corporate Songs Commissioned by Drug Companies Business Insider
Elios Therapeutics Announces the Appointment of Mark H.N. ... PR Newswire
CMS?s International Pricing Model For Medicare Part B Drugs ... healthaffairs.org
Antipsychotics in Young Patients: Results From the TEOSS Study Medscape
The Effect of Concomitant Treatment With SSRIs and Statins: A ... Am J Psychiatry
A Look at the Top Two Bio Clusters in the U.S.: California and ... Genetic Engineering & Biotechnology News
FDA Halves Recommended Lunesta Dose, Warns Effects Can Persist Into Next Day WREG NewsChannel 3
Urovant Sciences Is A Hidden Gem With A Blockbuster Drug Likely ... Nasdaq
Effect of Age at Onset on the Course of Major Depressive Disorder Am J Psychiatry
New innovations in mood disorders herald 'the edge of the future' Healio
Lithium in Breast Milk and Nursing Infants: Clinical Implications Am J Psychiatry
Atypical Antipsychotic Administration During Late Pregnancy ... Am J Psychiatry
Patent expiry looms: 18 blockbusters expose $37 billion to generic ... Pharmaceutical Online
Direct To Data - An Electronic Solution To Patient Diaries Clinical Leader
North Bay leaders in human resources management North Bay Business Journal
| For more news about Sepracor Inc. click here:
Sepracor Inc. News |
|
Website Width:
Background image: |
|  | |
|
|
![Sepracor Inc. - [Ticker: SEPR] chart](http://www.tr4der.com/chart/tr4der-SEPR-1-year.png)
